Amazon appoints leader of new pharmacy business

Amy Baxter | | Health Exec | Management

Months after acquiring online pharmacy PillPack for approximately $1 billion, Amazon has appointed a 14-year veteran with the company to lead its new pharmacy business, CNBC reported. Nader Kabbani has been named vice president of consumables, special projects.

The PillPack team reports to Kabbani, CNBC reported. Kabbani previously worked on Amazon’s Kindle platform and was vice president in the company’s Flex and logistics businesses. The pharmacy business represents a significant opportunity for Amazon as it continues to branch into new industries, particularly healthcare.

Amazon continues its push into the pharmacy business, and has appointed a 14-ye…

“With PillPack, Amazon is poised to take a slice of the growing home delivery market, though it could also potentially incorporate retail pharmacy offerings at Whole Foods locations, after buying the upscale grocery chain for more than $13 billion in 2017,” CNBC reported.

Amazon’s impact on the space has already been apparent, with stocks of other major pharmacies dropping at the time the company acquired PillPack.

See the full story below:

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.